Comparative analysis of the expression of cytokeratins (1, 10, 14, 16, 4), involucrin, filaggrin and e-cadherin in plane warts and epidermodysplasia verruciformis plane wart-type lesions

Journal of Cutaneous Pathology

Volumn 36, Issue 6, 2009, Pages 647-654

  Barcelos, Andrezza C N ^a   Sotto, Mirian N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 16; CYTOKERATIN 4; FILAGGRIN; INVOLUCRIN; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SKIN DEFECT; VERRUCA VULGARIS;

ADULT; CADHERINS; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATINS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROTEIN PRECURSORS; SKIN DISEASES;

EID: 65949096817     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01127.x     Document Type: Article

References (37)

1. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984 83 : 18s.
2. Lutzner MA. Epidermodysplasia verruciformis: an autosomal recessive disease characterized by viral warts and skin cancer - a model for viral oncogenesis. Bull Cancer 1978 65 : 165.
3. Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis. Arch Dermatol 1985 121 : 864.
4. Jablonska S, Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol 1994 186 : 157.
5. Oliveira WR, Carrasco S, Neto CF, Tyring S. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. J Dermatol 2003 30 : 203.
6. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006 18 : 362.
7. de Oliveira WR, Festa Neto C, Rady PL, Tyring SK. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2003 17 : 394.
8. Roncalli de Oliveira W, Neto CF, Rady PL, Tyring SK. Seborrheic keratosis-like lesions in patients with epidermodysplasia verruciformis. J Dermatol 2003 30 : 48.
9. Majewski S, Jablonska S. Current views on the role of papillomavirus in cutaneous oncogenesis. Int J Dermatol 2006 45 : 192.
10. Oliveira WRP, Rady PL, Festa Neto C, Rivitti EA, Tyring SK. Skin cancer in epidermodysplasia verruciformis patients from Brazil. J Eur Acad Dermatol Venereol 2006 20 : 1154.
11. Majewski S, Jablonska S. Human papillomavirus - associated tumors of the skin and mucosa. J Am Acad Dermatol 1997 36 : 659.
12. Astori G, Lavergne D, Benton C, et al. Human papillomavirus are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998 110 : 752.
13. Favre M, Orth G, Majewski S, Baloul S, Pura A, Jablonska S. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998 110 : 311.
14. Nuovo GJ, Ishag M. The histologic spectrum of epidermodysplasia verruciformis. Am J Surg Pathol 2000 24 : 1400.
15. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981 29 : 577.
16. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982 31 : 11.
17. Moll R, Moll I, Franke WW. Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res 1984 276 : 349.
18. Staquet MJ, Viac J, Thivolet J. Keratin polypeptide modifications induced by human papillomaviruses (HPV). Arch Dermatol Res 1981 271 : 83.
19. Stoler A, Kopan R, Duvic M, Fuchs E. Use of mono-specific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 1988 107 : 427.
20. Mullink H, Jiwa NM, Walboomers JMM, Horstman A, Vos W, Meijer CJLM. Demonstration of changes in cytokeratin expression in condylomata accuminata in relation to the presence of human papilloma virus as shown by a combination of immunohistochemistry and in situ hybridization. Am J Dermatopathol 1991 13 : 530.
21. Kallioinem M, Koivukangas V, Javirnen M, Oikarinen A. Expression of cytokeratins in regenerating human epidermis. Br J Dermatol 1995 133 : 830.
22. Kurokawa I, Mizutani H, Kusumoto K, et al. Cytokeratin, filaggrin, and p63 expression in reepithelialization during human cutaneous wound healing. Wound Repair Regen 2006 14 : 38.
23. Leigh IM, Navsaria H, Purkis PE, McKay LA, Bowden PE, Riddle PN. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 1995 133 : 501.
24. Nogueira-Castañon MCM, Maya TC, Neves RG. Expression of the cytokeratins in infectious and parasitic skin diseases associated with epidermal hyperplasia. An Bras Dermatol 2004 79 : 679.
25. Van Muijen GNP, Warnaar S, Ponec M. Differentiation-related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn and adult epidermis. Exp Cell Res 1987 171 : 331.
26. Watanabe S, Ichikawa E, Takahashi H, Otsuka F. Changes of cytokeratin and involucrin expression in squamous cell carcinomas of the skin during progression to malignancy. Br J Dermatol 1995 132 : 730.
27. Tada H, Hatoko M, Muramatsu T, Shirai T. Expression of e-cadherin in skin carcinomas. J Dermatol 1996 23 : 104.
28. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M. Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol 2004 26 : 372.
29. Hines MD, Jin HC, Wheelock MJ, Jensen PJ. Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes. J Cell Sci 1999 112 : 4569.
30. Wilding J, Vousden KH, Soutter WP, McCrea PD, Buono R, Pignatelli M. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Cancer Res 1996 56 : 5285.
31. Mathews K, Leong CM, Baxter L, et al. Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of e-cadherin. J Virol 2003 77 : 8378.
32. Fleckman P, Dale B, Holbrook K. Profilaggrin, a high molecular-weight precursor of filaggrin in humor epidermis and cultured keratinocytes. J Invest Dermatol 1985 85 : 507.
33. Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small praline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified envelope. J Cell Biol Chem 1995 270 : 17702.
34. Watt F. Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 1983 81 : 100s.
35. Ishida-Yamamoto A, Tonja K, Matsuo S, Kuroki T, Iizuka H. Involucrin an SPRR are synthesizes sequentially in differentiating cultured epidermal cells. J Invest Dermatol 1997 108 : 12.
36. Woodworth CD, Waggoner S, Barcers W, Stoler MH, DiPaolo MH. Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res 1990 50 : 3709.
37. Smoller BR, Krueger J, McNutt NS, Hsu A. 'Activated' keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin. Mod Pathol 1990 3 : 171.